Contineum Therapeutics, Inc. (CTNM) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $231.0K | -55.1% |
| 2024 | $514.0K | +24.2% |
| 2023 | $414.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $231.0K | -55.1% |
| 2024 | $514.0K | +24.2% |
| 2023 | $414.0K | — |